1 Belhadj Y, Grande P, Seisen T et al. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes. BJU Int 2019; 123: 618-23.
2 Hafner C, Knuechel R, Stoehr R, Hartmann A. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 2002; 101: 1-6.
3 Milojevic B, Dzamic Z, Kajmakovic B, Milenkovic Petronic D, Sipetic Grujicic S. Urothelial carcinoma: Recurrence and risk factors. J BUON 2015; 20: 391-8.
4 Xylinas E, Colin P, Audenet F et al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol 2013; 31: 61-8.
5 Yamashita S, Ito A, Mitsuzuka K et al. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Int J Urol 2016; 23: 378-84.
6 Elalouf V, Xylinas E, Klap J et al. Bladder recurrence after radical nephroureterectomy: predictors and impact on oncological outcomes. Int J Urol 2013; 20: 1078-83.
7 Hou G, Zheng Y, Zhang L et al. Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma. World J Urol 2020; 38: 1969-75.
8 Kang M, Jeong CW, Kwak C, Kim HH, Ku JH. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision. Yonsei Med J 2015; 56: 375-81.
9 Nazzani S, Preisser F, Mazzone E et al. Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis. Eur Urol Focus 2020; 6: 298-304.
10 Chromecki TF, Bensalah K, Remzi M et al. Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 2011; 8: 440-7.
11 Novara G, De Marco V, Gottardo F et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 2007; 110: 1715-22.
12 Abouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 2010; 76: 895-901.
13 Matulay JT, Soloway M, Witjes JA et al. Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG). BJU Int 2020; 125: 497-505.
14 Pietzak EJ, Bagrodia A, Cha EK et al. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. Eur Urol 2017; 72: 952-9.
15 Kang CH, Yu TJ, Hsieh HH et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003; 98: 1620-6.
16 Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology 2014; 84: 1420-6.
17 Shigeta K, Kikuchi E, Hagiwara M et al. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma. J Urol 2017; 198: 1278-85.
18 Shariat SF, Godoy G, Lotan Y et al. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 2010; 105: 1672-7.
19 Chromecki TF, Ehdaie B, Novara G et al. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol 2011; 29: 473-80.
20 Yancik R, Havlik RJ, Wesley MN et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996; 6: 399-412.
21 Taccoen X, Valeri A, Descotes JL et al. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol 2007; 51: 980-7.